5Schellekens GA,Visser H,De Jong BAW,et al.The diagnosticproperties 0f rheumatoid arthritis antibodies recognizing a cycliccitrullinated peptide[J].AIthritis Rheum,2000,43(1):155-163. 被引量：1
6K root E JJA,De Jong BAW,Van L eeuwen M A,et a l.T he prognostic value of value of anti-citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis[J].Arthritis Rheum,2000,43(10):1831-1835. 被引量：1
7Nicola B,GiovaIlni M,Elio T,et al.Diagnostic accuracy of the Anti-citrulline Antibody assay for rheumatoid arthritis[J].Clinchem,2001,47(8):1089-1093. 被引量：1
2Aletaha D,Neogi T,Silman AJ,et al.2010 rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Ann Rheum Dis,2010,69:1580-1588. 被引量：1
3Rojas-Serrano J,Burgos-Vargas R,Perez LL,et al.Very recent onset arthritis:the value of initial rheumatologist evaluation and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis.Clin Rheumatol,2009,28:1135-1139. 被引量：1
4Liu X,Jia R,Zhao J,et al.The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.J Rheumatol,2009,36:1136-1142. 被引量：1
5Syversen SW,Goll GL,van der Heijde D,et al.Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin:results from a 10-year prospective study.Ann Rheum Dis,2010,69:345-351. 被引量：1
6Zhao Y,Tian X,Li Z.Prevalence and clinical significance of antibodies to citrullinated fihrinogen(ACF)in Chinese patients with rheumatoid arthritis.Clin Rheumatol,2007,26:1505-1512. 被引量：1
7Nielen MM,van der Horst AR,van Schaardenburg D,et al.Antibodies to citrullinated human fibrinogen(ACF)have diagnostic and prognostic value in early arthritis.Ann Rheum Dis,2005,64:1199-1204. 被引量：1
8Saulot V,Vittecoq O,Charlionet R,et al.Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.Arthritis Rheum,2002,46:1196-1201. 被引量：1
9Lundberg K,Kinloch A,Fisher BA,et al.Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.Arthritis Rheum,2008,58:3009-3019. 被引量：1
10Mullazehi M,Mathsson L,Lampa J,et al.High anti-collagen type-Ⅱ antibody levels and induction of proinflammatory cytokines by anti-collagen antibedy-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset.Ann Rheum Dis,2007,66:537-541. 被引量：1
7Schellekens GA, Visser H, de Jong BA, et al. The diagnostic prop- erties of rheumatoid arthritis antibodies recognizing a cyclic citrul- linated peptide[J]. Arthritis Rheum,2000,43(1) :155-163. 被引量：1
8Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, et al. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthri- tis in patients with early arthritis[J]. J Rheumatol, 2002,29 (10) : 2074-2076. 被引量：1
9Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classi- fication criteria: an American College of Rheumatology/European League AgainstRheumatism collaborative initiative [ J ]. Arthritis Rheum, 2010,62(9) :2569 -2581. 被引量：1
10Pedersen JK,Kjaer NK,Svendsen AJ,et al.Incidence of rheuma-toid arthritis from 1995 to 2001:impact of ascertainment from mul-tiple sources[J].Rheumatol Int,2009,29(4):411-415. 被引量：1
